View Item 

Show simple item record

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises
dc.contributor.authorde Lautour, Hugh
dc.contributor.authorTaylor, William J.
dc.contributor.authorAdebajo, Ade
dc.contributor.authorAlten, Rieke
dc.contributor.authorBurgos‐vargas, Ruben
dc.contributor.authorChapman, Peter
dc.contributor.authorCimmino, Marco A.
dc.contributor.authorda Rocha Castelar Pinheiro, Geraldo
dc.contributor.authorDay, Ric
dc.contributor.authorHarrold, Leslie R.
dc.contributor.authorHelliwell, Philip
dc.contributor.authorJanssen, Matthijs
dc.contributor.authorKerr, Gail
dc.contributor.authorKavanaugh, Arthur
dc.contributor.authorKhanna, Dinesh
dc.contributor.authorKhanna, Puja P.
dc.contributor.authorLin, Chingtsai
dc.contributor.authorLouthrenoo, Worawit
dc.contributor.authorMcCarthy, Geraldine
dc.contributor.authorVazquez‐mellado, Janitzia
dc.contributor.authorMikuls, Ted R.
dc.contributor.authorNeogi, Tuhina
dc.contributor.authorOgdie, Alexis
dc.contributor.authorPerez‐ruiz, Fernando
dc.contributor.authorSchlesinger, Naomi
dc.contributor.authorRalph Schumacher, H.
dc.contributor.authorScirè, Carlo A.
dc.contributor.authorSingh, Jasvinder A.
dc.contributor.authorSivera, Francisca
dc.contributor.authorSlot, Ole
dc.contributor.authorStamp, Lisa K.
dc.contributor.authorTausche, Anne‐kathrin
dc.contributor.authorTerkeltaub, Robert
dc.contributor.authorUhlig, Till
dc.contributor.authorvan de Laar, Mart
dc.contributor.authorWhite, Douglas
dc.contributor.authorYamanaka, Hisashi
dc.contributor.authorZeng, Xuejun
dc.contributor.authorDalbeth, Nicola
dc.date.accessioned2017-01-06T20:46:43Z
dc.date.available2017-07-10T14:31:42Zen
dc.date.issued2016-05
dc.identifier.citationde Lautour, Hugh; Taylor, William J.; Adebajo, Ade; Alten, Rieke; Burgos‐vargas, Ruben ; Chapman, Peter; Cimmino, Marco A.; da Rocha Castelar Pinheiro, Geraldo; Day, Ric; Harrold, Leslie R.; Helliwell, Philip; Janssen, Matthijs; Kerr, Gail; Kavanaugh, Arthur; Khanna, Dinesh; Khanna, Puja P.; Lin, Chingtsai; Louthrenoo, Worawit; McCarthy, Geraldine; Vazquez‐mellado, Janitzia ; Mikuls, Ted R.; Neogi, Tuhina; Ogdie, Alexis; Perez‐ruiz, Fernando ; Schlesinger, Naomi; Ralph Schumacher, H.; Scirè, Carlo A. ; Singh, Jasvinder A.; Sivera, Francisca; Slot, Ole; Stamp, Lisa K.; Tausche, Anne‐kathrin ; Terkeltaub, Robert; Uhlig, Till; van de Laar, Mart; White, Douglas; Yamanaka, Hisashi; Zeng, Xuejun; Dalbeth, Nicola (2016). "Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises." Arthritis Care & Research 68(5): 667-672.
dc.identifier.issn2151-464X
dc.identifier.issn2151-4658
dc.identifier.urihttps://hdl.handle.net/2027.42/134851
dc.publisherWiley Periodicals, Inc.
dc.titleDevelopment of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelGeriatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134851/1/acr22741_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134851/2/acr22741.pdf
dc.identifier.doi10.1002/acr.22741
dc.identifier.sourceArthritis Care & Research
dc.identifier.citedreferenceKhanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012; 64: 1431 â 46.
dc.identifier.citedreferenceSchumacher R. The pathogenesis of gout. Cleve Clin J Med 2008; 75: S2 â 4.
dc.identifier.citedreferenceProwse RL, Dalbeth N, Kavanaugh A, Adebajo AO, Gaffo AL, Terkeltaub R, et al. A Delphi exercise to identify characteristic features of gout: opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol 2013; 40: 498 â 505.
dc.identifier.citedreferenceTaylor WJ, Schumacher HR, Baraf HS, Chapman P, Stamp L, Doherty M, et al. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 2008; 67: 888 â 91.
dc.identifier.citedreference1000Minds. 2014. URL: www.1000Minds.com.
dc.identifier.citedreferenceSurvey Monkey. 2014. URL: www.surveymonkey.com.
dc.identifier.citedreferenceBykerk VP, Massarotti EM. The new ACR/EULAR remission criteria: rationale for developing new criteria for remission. Rhematology (Oxford) 2012; 51: vi16 â 20.
dc.identifier.citedreferenceTaylor WJ, Brown M, Aati O, Weatherall M, Dalbeth N. Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria? Arthritis Care Res (Hoboken) 2013; 65: 1259 â 64.
dc.identifier.citedreferenceScire CA, Viroli C, Manara M, Cimmino MA, Govoni M, Salaffi F, et al. Development and preliminary validation of a candidate disease activity score for gout [abstract]. Ann Rheum Dis 2013; 72: 48.
dc.identifier.citedreferenceDalbeth N, McQueen FM, Singh JM, MacDonald PA, Edwards NL, Schumacher HR, et al. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol 2011; 38: 1458 â 61.
dc.identifier.citedreferenceSingh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, et al. Patientâ reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 2011; 38: 1452 â 7.
dc.identifier.citedreferenceSingh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, et al. OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol 2014; 41: 569 â 73.
dc.identifier.citedreferenceGrainger R, Taylor W, Dalbeth N, Perezâ Ruiz F, Singh JA, Waltrip RW, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009; 36: 2346 â 55.
dc.identifier.citedreferenceGrainger R, Taylor W. Establishing outcome domains for evaluating treatment of acute and chronic gout. Curr Opin Rheumatol 2008; 20: 173 â 8.
dc.identifier.citedreferenceTaylor W. Measurement of outcome in gout. Ind J Rheumatol 2013; 8: S11 â 5.
dc.identifier.citedreferenceSivera F, Andres M, Carmona L, Kydd AS, Moi J, Seth R, et al. Multinational evidenceâ based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2014; 73: 328 â 55.
dc.identifier.citedreferenceRees F, Hul M, Doherty M. Optimizing current treatment of gout. Nat Rev Rheumatol 2014; 10: 271 â 83.
dc.identifier.citedreferenceAati O, Taylor WJ, Siegert RJ, Horne A, House ME, Tan P, et al. Development of a patientâ reported outcome measure of tophus burden: the tophus impact questionnaire (TIQâ 20). Ann Rheum Dis 2014; 74: 2144 â 50.
dc.identifier.citedreferenceDalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010; 62: 1549 â 56.
dc.identifier.citedreferenceTaylor WJ, Singh JA, Saag K, Dalbeth N, MacDonald PA, Edwards NL, et al. Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol 2011; 38: 1467 â 70.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acr22741_am.pdf
Size:
380.4KB
Format:
PDF
View/Open
Name:
acr22741.pdf
Size:
181.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.